Avalo Therapeutics, Inc. (AVTX): SCHEDULE 13G/A filed Aug 14, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 14, 2026

Accession number

0001727492-26-000021

Filer

Avalo Therapeutics, Inc. (CIK 1534120)